Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

How has the insulin patch pumps market size evolved in recent years?

The insulin patch pump industry has seen a fast-paced growth in recent years. The market value will rise from $1.42 billion in 2024 to $1.57 billion in 2025, showcasing a compound annual growth rate (CAGR) of 10.2%. Several factors have contributed to the development during the historic period, including a higher rate of diabetes, patients’ inclination towards non-invasive delivery methods, an increase in the elderly population, enhanced safety issues, and advancements in miniaturization and form factor improvements.

What are the predictions for the insulin patch pumps market size in the coming years?

The market size of insulin patch pumps is projected to experience significant expansion in the forthcoming years, skyrocketing to $2.37 billion in 2029 with a compound annual growth rate (CAGR) of 10.9%. The factors contributing to this predicted growth in the forecast period include the rising trend of telehealth, growth in pediatric diabetes cases, expanded awareness about diabetes, environmental and sustainability issues, and escalating healthcare initiatives. Key trends to watch out for during this forecast period include the growth in quantum computing design tools, rising integration of artificial intelligence and machine learning, adoption of digital twin simulations, advancements in custom IC design tools, and expansion in high-level synthesis tools.

Get your insulin patch pumps market report here!

https://www.thebusinessresearchcompany.com/report/insulin-patch-pumps-global-market-report

What key factors are fueling the growth of the insulin patch pumps market?

A global increase in diabetes cases is anticipated to fuel the expansion of the insulin patch pumps market during the projected timeframe. Diabetes, a critical global disease, originates from various factors such as dietary habits and lifestyle choices. Insulin patch pumps offer an easier way to administer insulin directly into the body, which is why many diabetes patients prefer them over insulin injections. As diabetes becomes more prevalent, the demand for insulin patch pumps rises. For example, the UK’s Office for Health Improvement & Disparities reported in March 2024 that, between March 2022 and March 2023, the portion of people with type 1 diabetes who received all eight suggested care processes saw a rise by 22%, and for those with type 2 diabetes, it increased by 21%. Furthermore, the percentage of individuals achieving target HbA1c levels soared to 37.9%, marking the highest figure ever reported by the National Diabetes Audit (NDA). Consequently, the growing global occurrence of diabetes will boost the insulin patch pumps market’s expansion.

How is the global insulin patch pumps market divided into key segments?

The insulin patch pumps market covered in this report is segmented –

1) By Type: Traditional Insulin Pumps, Smart Insulin Pump, Disposable Insulin Pumps

2) By Mode: Basal, Bolus

3) By Pump Type: Tethered Pump, Patch Pump

4) By Application: Type 1 Diabetes, Type 2 Diabetes

5) By End-User: Hospital, Clinics, Laboratories, Other End-Users

Subsegments:

1) By Traditional Insulin Pumps: Continuous Subcutaneous Insulin Infusion (CSII) Pumps, Manual Bolus Delivery Pumps

2) By Smart Insulin Pumps: Connected Insulin Pumps, Automated Insulin Delivery Systems

3) By Disposable Insulin Pumps: Pre-filled Disposable Insulin Pumps, Patch-Style Disposable Pumps

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=6486&type=smp

Who are the key firms paving the way for growth in the insulin patch pumps market?

Major companies operating in the insulin patch pumps market include Cellnovo Group SA, Insulet Corporation, Medtronic PLC, Tandem Diabetes Care Inc., Hoffmann-La-Roche AG, AMF Medical SA, Abbott Laboratories Inc., Becton Dickinson and Company, Braun Melsungen AG, Cequr SA, Debiotech SA, DexCom Inc., Eoflow Co. Ltd., Embecta Corp., Hospira Inc., Johnson & Johnson Services Inc., LifeScan Inc., Sanofi S.A., Univlabs Technologies Pvt. Ltd., Ypsomed Holding AG, Zealand Pharma A/S, Bigfoot Biomedical Inc., Echo Therapeutics Inc., Glysens Inc., Medella Health Ltd., Roche Diabetes Care GmbH, Valeritas Inc., 3S Corporation, Apex Medical Devices

Which trends are expected to transform the insulin patch pumps market?

The growing trend in the insulin patch pumps market revolves around the integration of advanced technologies into these devices. This includes syncing with smartphones and making insulin delivery automated. This new generation of insulin pumps and continuous glucose monitors are becoming smarter, vastly reducing the need for manual intervention in delivering insulin. As an illustration, Insulet Corporation, an innovative medical device firm from the US, secured FDA approval for its Omnipod 5 automated Insulin delivery system in January 2022, for individuals with type 1 diabetes who are 6 years or older. Notably, it is the first and only system that delivers insulin automatically without any tubes and can be controlled via a compatible smartphone. It eliminates the need for multiple daily injections, tubes, and fingersticks, thus making diabetes management significantly simpler.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=6486

What regions are contributing significantly to the growth of the insulin patch pumps market?

North America was the largest region in the insulin patch pumps market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the insulin patch pumps market report include Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Browse Through More Similar Reports By The Business Research Company:

Insulin Drugs Global Market Opportunities And Strategies To 2031: COVID-19 Growth And Change

https://www.thebusinessresearchcompany.com/report/insulin-drugs-market

Injectable Drug Delivery Devices Global Market Opportunities And Strategies To 2031: COVID-19 Impact and Recovery

https://www.thebusinessresearchcompany.com/report/injectable-drug-delivery-devices-market

Therapeutic Proteins Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/therapeutic-proteins-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: